Pharmaceutical

Specialty pharmacies, says at least one group, represent the fastest-growing segment of the pharmaceutical market.
News
|

Promising future for specialty pharmacies

Taking a quick look at the market and the challenges in what at least one group says represents the fastest-growing segment of the pharmaceutical market.
E-BOOK SPECIAL REPORT
44 Best Package Designs: 2015
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative package designs of the past year.
News
|

FDA confirms generic drug ownership change

The company who took ownership, also successfully manufactured first batch of unique tablets.
Winpak: Cold Form laminate
Materials Product Brief
|

Winpak: Cold form laminate

Designed for sensitive, hygroscopic pharmaceutical and biopharmaceutical products.

Novartis package features child-resistant design

Novartis Exforge HCT, for treating high blood pressure, is packaged by PCI, using the MWV Shellpak Renew child-resistant design to support patients in taking their daily medication.

Eli Lilly compliance pack earns honors

The 2014 HCPC Compliance Package of the Year First Runner Up was awarded to the Eli Lilly Strattera® Physician Sample Pack from PCI, which contains medication for the treatment of attention-deficit/hyperactivity disorder (ADHD).

HCPC Compliance Package of the Year

Astra Zeneca’s SEROQUEL XR® 14-Day Sample Kit for Acute Bipolar Depression is in a calendarized blister pack from MWV that promotes patient adherence for this medication’s complex dosing regimen.
•	2014 HCPC Compliance Package of the Year: Astra Zeneca SEROQUEL XR® 14-Day Sample Kit for Acute Bipolar Depression from MWV.
Feature Article
|

Astra Zeneca, Eli Lilly, Novartis win HCPC honors

The Healthcare Compliance Packaging Council unveils the most innovative pharmaceutical packages designed to improve patient adherence.
FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids
News
|

FDA issues final guidance on the evaluation and labeling of abuse-deterrent opioids

The U.S. Food and Drug Administration on April 1, 2015 issued a final guidance to assist industry in developing opioid drug products with potentially abuse-deterrent properties.
Syringes
Feature Article
|

Pharmapack Europe covered lots of ground

Exclusive coverage fom Pharmapack Europe includes strategies for handling injectables, updates on new regs for med devices, and a look at the challenges of veterinary drugs.
News
|

FDA issues guidance for repackaging

The U.S. Food and Drug Administration issued a Feb. 2015 Guidance for Industry titled, “Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities,” that is being distributed for comment purposes only.

Pages

Subscribe to Pharmaceutical

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.